3x directors increasing holdings concurrently, I would suggest may signal a bottom either in the company or the greater market. As Australia looks to re-open, those elective surgery delays which have hurt the company bottom line in the last FY may fade this financial year.
With the cost cutting the company has been working on, this would be very positive - but I would like to see where organic growth in the business will come from now that we have slimmed down and are pushing through the challenging times COVID has bought us all.
3x directors increasing holdings concurrently, I would suggest...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.010(2.33%) |
Mkt cap ! $695.2M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 42.5¢ | 41.0¢ | $1.013M | 2.435M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 54906 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PGC (ASX) Chart |